Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world

Clinical Infectious Diseases

Volumn 32, Issue 12, 2001, Pages 1706-1709

  Adachi, Javier A ^a   Jiang, Zhi Dong ^a   Mathewson, John J ^a,b   Verenkar, Mangala P ^c   Thompson, Sharon ^d   Martinez Sandoval, Francisco ^e   Steffen, Robert ^f   Ericsson, Charles D ^f   DuPont, Herbert L ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c GOA MEDICAL COLLEGE   (India)

^d Cornwell Regional Hospital ^*  (Jamaica)

^e Universidad Autonoma de Guadalajara   (United States)

^f UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIUM ADHERENCE; ENZYME IMMUNOASSAY; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; HUMAN; INDIA; JAMAICA; MAJOR CLINICAL STUDY; MALE; MEXICO; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TRAVELLER DIARRHEA;

ADULT; DIARRHEA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INDIA; JAMAICA; MALE; MEXICO; PREVALENCE; TRAVEL; TUMOR CELLS, CULTURED; WORLD HEALTH;

EID: 0034995486     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/320756     Document Type: Article

References (30)

1. Prevention and treatment of traveler's diarrhea
2. Traveler's diarrhea: Epidemiology, prevention and self-treatment
3. Travelers diarrhea: National Institutes of Health Consensus Conference
4. Diarrheagenic Escherichia coli
5. A newly recognized cause of traveler's diarrhea: Enteroadherent Escherichia coli
6. An adhesive factor found in strains of Escherichia coli belonging to the traditional enteropathogenic serotypes
7. Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells
8. Rifaximin for the treatment of traveler's diarrhea: A randomized, double-blind clinical trial versus ciprofloxacin
9. A double-blind, randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Mexico and Jamaica
10. Risk and aetiology of diarrhoea at various tourist destinations
11. Utility of oligodeoxyribonucleotide probes for detecting enterotoxigenic Escherichia coli
12. Comparison of two assay methods for patterns of adherence to HEp-2 cells of Escherichia coli from patients with diarrhea
13. DNA fingerprinting of Enterococcus faecium by pulse-field gel electrophoresis may be a useful epidemiologic tool
14. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for traveler's diarrhea: A placebo-controlled trial
15. Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico
16. Phylogenetic analysis of enteroaggregative and diffusely adherent Escherichia coli
17. Enteroaggregative Escherichia coli elaborate a heat-stable enterotoxin demonstrable in an in vitro rabbit intestinal model
18. Aggregative adherence fimbriae I of enteroaggregative Escherichia coli mediate adherence to HEp-2 cells and hemaglutination of human erythrocytes
19. Aggregative adherence fimbria. II. A second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli
20. Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells
21. Prevalence of Escherichia coli strains with localized, diffuse, and aggregative adherence to HeLa cells in infants with diarrhea and matched controls
22. Association of Escherichia coli HEp-2 adherence patterns with type and duration of diarrhea
23. Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers
24. Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India
25. Persistent diarrhea in Northeast Brazil: Etiologies and interactions with malnutrition
26. Successful treatment of diarrhea disease associated with enteroaggregative Escherichia coli in adults with human immunodeficiency virus
27. HEp2 cell adherent Escherichia coli in patients with human immunodeficiency virus-associated diarrhea
28. Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: Clinical response to ciprofloxacin
29. Enteroaggregative Escherichia coli strains as a cause of traveler's diarrhea: A case-control study
30. Characterization of enteroaggregative Escherichia coli isolated from outbreaks of diarrhoeal disease in England